Chandrasekhar Bal
18PUBLICATIONS
3CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (18)
Sort by Publication Date:
|Feb 04, 2025
Low-Dose Versus High-Dose Lenvatinib in Radioiodine Refractory Differentiated Thyroid Cancer-A Real-World Safety and Efficacy Analysis.Jeepalem Sai Moulika, Kunal Ramesh Chandekar, Shubha Gadde Ravindra
|Mar 12, 2024
[177Lu]Lu-PSMA-617 as first-line systemic therapy in patients with metastatic castration-resistant prostate cancer: a real-world study.Swayamjeet Satapathy, Madhav Prasad Yadav, Sanjana Ballal
|Jan 12, 2024
Optimal Cumulative I-131 Activity in Metastatic Differentiated Thyroid Cancer: Balancing Efficacy and Adverse Events.Mangu Srinivas Bharadwaj, Sanjana Ballal, Chandrasekhar Bal
|Dec 05, 2023
Impact of radioiodine therapy on recurrence and survival outcomes in intermediate-risk papillary thyroid carcinoma -A systematic review and meta-analysis.Kunal Ramesh Chandekar, Swayamjeet Satapathy, Chandrasekhar Bal
|Nov 06, 2023
Therapeutic potential of [177Lu]Lu-DOTAGA-FAPi dimers in metastatic breast cancer patients with limited treatment options: efficacy and safety assessment.Madhav P Yadav, Sanjana Ballal, Marcel Martin
Pageof 3